Citigroup’s Bioventus BVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $124K | Sell |
18,723
-10,298
| -35% | -$68.2K | ﹤0.01% | 3584 |
|
|
2025
Q1 | $266K | Sell |
29,021
-2,951
| -9% | -$27K | ﹤0.01% | 3275 |
|
|
2024
Q4 | $336K | Buy |
31,972
+4,527
| +16% | +$47.5K | ﹤0.01% | 3266 |
|
|
2024
Q3 | $328K | Buy |
27,445
+18,923
| +222% | +$226K | ﹤0.01% | 3261 |
|
|
2024
Q2 | $49K | Sell |
8,522
-121,337
| -93% | -$698K | ﹤0.01% | 3863 |
|
|
2024
Q1 | $675K | Buy |
129,859
+5,336
| +4% | +$27.7K | ﹤0.01% | 2649 |
|
|
2023
Q4 | $656K | Buy |
124,523
+71,990
| +137% | +$379K | ﹤0.01% | 2495 |
|
|
2023
Q3 | $173K | Buy |
52,533
+52,146
| +13,474% | +$172K | ﹤0.01% | 3049 |
|
|
2023
Q2 | $1.12K | Buy |
387
+316
| +445% | +$913 | ﹤0.01% | 4577 |
|
|
2023
Q1 | $76 | Sell |
71
-911
| -93% | -$975 | ﹤0.01% | 4565 |
|
|
2022
Q4 | $2.56K | Sell |
982
-16,834
| -94% | -$43.9K | ﹤0.01% | 4413 |
|
|
2022
Q3 | $125K | Sell |
17,816
-1,331
| -7% | -$9.34K | ﹤0.01% | 3290 |
|
|
2022
Q2 | $131K | Buy |
19,147
+1,752
| +10% | +$12K | ﹤0.01% | 3403 |
|
|
2022
Q1 | $245K | Sell |
17,395
-799
| -4% | -$11.3K | ﹤0.01% | 3287 |
|
|
2021
Q4 | $264K | Sell |
18,194
-1,331
| -7% | -$19.3K | ﹤0.01% | 3442 |
|
|
2021
Q3 | $276K | Buy |
19,525
+19,130
| +4,843% | +$270K | ﹤0.01% | 3223 |
|
|
2021
Q2 | $7K | Sell |
395
-114
| -22% | -$2.02K | ﹤0.01% | 5083 |
|
|
2021
Q1 | $8K | Buy |
+509
| New | +$8K | ﹤0.01% | 5080 |
|